A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse

Background and Purpose: Effective relapse treatment is critical for minimizing disability in patients with multiple sclerosis (MS). Repository corticotropin injection (RCI; Acthar® Gel) has demonstrated efficacy for the treatment of MS exacerbations. However, there is limited real-world evidence ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplan, Jeffrey, Miller, Tamara, Baker, Matthew, Due, Bryan, Zhao, Enxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783159/
https://www.ncbi.nlm.nih.gov/pubmed/33414758
http://dx.doi.org/10.3389/fneur.2020.598496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783159/
https://www.ncbi.nlm.nih.gov/pubmed/33414758
http://dx.doi.org/10.3389/fneur.2020.598496

Ejemplares similares